Please use this identifier to cite or link to this item:
Title: Unmasking the hidden tuberculosis mortality burden in a large postmortem study in Maputo Central Hospital, Mozambique
Author: García-Basteiro, Alberto L.
Hurtado, Juan Carlos
Castillo, Paola
Fernandes, Fabiola
Navarro, Mireia
Lovane, Lucilia
Casas, Isaac
Quintó, Llorenç
Jordao, Dercio
Ismail, Mamudo Rafik
Lorenzoni, Cesaltina
Carrilho, Carla
Sanz, Ariadna
Rakislova, Natalia
Mira, Aurea
Álvarez Martínez, Míriam
Cossa, Anelsio
Cobelens, Frank
Mandomando, Inácio
Vila Estapé, Jordi
Bassat Orellana, Quique
Menéndez, Clara
Ordi i Majà, Jaume
Martínez Yoldi, Miguel Julián
Keywords: Tuberculosi
Issue Date: 25-Jul-2019
Publisher: European Respiratory Society
Abstract: Sensitive tools are needed to accurately establish the diagnosis of tuberculosis (TB) at death, especially in low-income countries. The objective of this study was to evaluate the burden of TB in a series of patients who died in a tertiary referral hospital in sub-Saharan Africa using an in-house real time PCR (TB-PCR) and the Xpert MTB/RIF Ultra (Xpert Ultra) assay.Complete diagnostic autopsies were performed in a series of 223 deaths (56.5% being HIV-positive), including 54 children, 57 maternal deaths and 112 other adults occurring at the Maputo Central Hospital, Mozambique. TB-PCR was performed in all lung, cerebrospinal fluid and central nervous system samples in HIV-positive patients. All samples positive for TB-PCR or showing histological findings suggestive of TB were analysed with the Xpert Ultra assay.TB was identified as the cause of death in 31 patients: 3/54 (6%) children, 5/57 (9%) maternal deaths and 23/112 (21%) other adults. The sensitivity of the main clinical diagnosis to detect TB as the cause of death was 19.4% (95% CI: 7.5-37.5) and the specificity was 97.4% (94.0-99.1) compared to autopsy findings. Concomitant TB (TB disease in a patient dying of other causes) was found in 31 additional cases. Xpert Ultra helped to identify 15 cases of concomitant TB. In 18 patients, " - " DNA was identified by TB-PCR and Xpert Ultra in the absence of histological TB lesions. Overall, 62 cases (27.8%) had TB disease at death and 80 (35.9%) had TB findings.The use of highly sensitive, easy to perform molecular tests in complete diagnostic autopsies may contribute to identifying TB cases at death that would have otherwise been missed. Routine use of these tools in certain diagnostic algorithms for hospitalised patients needs to be considered. Clinical diagnosis showed poor sensitivity for the diagnosis of TB at death.
Note: Versió postprint del document publicat a:
It is part of: European Respiratory Journal, 2019
Related resource:
ISSN: 0903-1936
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Garcia-BasteiroAL_Eur_Respir_J_2019_Postprint.pdf823.08 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.